Animal study · mice
SLU-PP-332 improved ejection fraction and survival in mice
Checked against the paper Animal studyPublished by PepVault
The takeaway
This mouse study is early evidence that SLU-PP-332 can protect heart function and survival in heart failure. It is not a human result.
- Kind
- Animal study
- Studied in
- Mice
- Published
- 2024
- Journal
- Circulation
What they tested
The team wanted to know whether SLU-PP-332, a newly designed drug that switches on the estrogen-related receptors ERRα and ERRγ, could protect the heart in mice with heart failure.
How the study was done
A preclinical study in mice with heart failure caused by pressure overload. SLU-PP-332 was tested alongside a second, different agonist, SLU-PP-915, with gene activity, metabolite and genetic tests in mice and in lab-grown cells.

What they found
In mice with pressure overload heart failure, SLU-PP-332 and SLU-PP-915 both improved ejection fraction (the share of blood the heart pumps out with each beat), reduced fibrosis (scar-like tissue) and increased survival. Neither changed cardiac hypertrophy, the thickening of the heart muscle. In the mouse heart, the drugs switched on many genes tied to fatty acid use and mitochondria, and largely brought fat and energy-related metabolites back toward normal after 6 weeks of pressure overload. Genetic tests in mice and cells showed that ERRγ was the main receptor behind the heart protection.
What it doesn’t show
This was work in mice and cells, so it does not show what SLU-PP-332 does in people with heart failure. It tested one type of heart failure model.
The paper
Xu et al. Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. Circulation. 2024.
The compound
More studies on SLU-PP-332
- SLU-PP-332 cut fat mass and improved insulin sensitivity in obese miceAnimal study · mice · 2024
- SLU-PP-332 increased exercise endurance in miceAnimal study · mice · 2023
- SLU-PP-332 reversed age-related kidney changes in old miceAnimal study · mice · 2023
- Every study on SLU-PP-332
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.